Altria Group is one of the largest tobacco companies in the United States, with a portfolio of leading nicotine brands serving U.S. tobacco consumers aged 21 and above. The company’s vision is “Moving Beyond Smoking,” which focuses on responsibly transitioning adult smokers to a smoke-free future, competing in the growing smoke-free nicotine market, and exploring new growth opportunities beyond both the United States and nicotine. While cigarettes remain its largest business, Altria is increasingly investing in reduced-risk nicotine products as consumer preferences evolve. The company generates substantially all of its revenue from customers in the United States.
Altria operates through several wholly owned subsidiaries that serve different nicotine product categories. Philip Morris USA (PM USA) manufactures and sells cigarettes, including the iconic Marlboro brand, which has remained the best-selling cigarette brand in the United States for more than 50 years. John Middleton Co. produces machine-made large cigars under the Black & Mild brand. U.S. Smokeless Tobacco Company (USSTC) manufactures moist smokeless tobacco products such as Copenhagen, Skoal, and Red Seal, while Helix Innovations produces on! oral nicotine pouches. Through NJOY, Altria also participates in the e-vapor market with FDA-authorized vaping products. In addition, the company owns a 75% economic interest in Horizon Innovations, a joint venture with Japan Tobacco that will commercialize heated tobacco products in the U.S. upon receiving FDA authorization.
To support these businesses, Altria also operates Altria Group Distribution Company, which manages domestic sales and distribution, and Altria Client Services, which provides research, product development, regulatory, legal, finance, and consumer engagement services across the organization. As of 2025, the company reports three operating segments—Smokeable Products, Oral Tobacco Products, and E-Vapor Products—while continuing to invest in next-generation smoke-free technologies that align with its long-term strategic vision.
Business Segments
Altria Group operates through three primary business segments, each focused on a different category of nicotine products. This diversified portfolio enables the company to serve adult tobacco consumers across both traditional and smoke-free product categories while reducing dependence on cigarettes alone.
Smokeable Products is Altria’s largest and most profitable segment. It includes cigarettes manufactured by Philip Morris USA, led by the flagship Marlboro brand, as well as machine-made large cigars produced by John Middleton, including the Black & Mild brand. This segment continues to generate the majority of the company’s revenue and operating income.
Oral Tobacco Products includes moist smokeless tobacco products such as Copenhagen, Skoal, and Red Seal, manufactured by U.S. Smokeless Tobacco Company (USSTC). The segment also includes modern oral nicotine pouches marketed under the on! brand through Helix Innovations, reflecting Altria’s shift toward smoke-free alternatives.
E-Vapor Products consists primarily of NJOY, Altria’s electronic vaping business. NJOY develops and markets FDA-authorized e-vapor devices and consumables, strengthening the company’s presence in the rapidly growing reduced-risk nicotine market.
In addition to these reportable segments, Altria reports an “All Other” category, which includes its 75% ownership in Horizon Innovations, a joint venture with Japan Tobacco to commercialize heated tobacco products in the United States, Helix International, and research and development activities focused on future nicotine technologies.
Industry Background and the Problem
The U.S. tobacco industry is undergoing one of the most significant transformations in its history. While combustible cigarettes remain the largest nicotine category, adult consumer preferences are gradually shifting toward smoke-free alternatives, including oral nicotine pouches, e-vapor products, and heated tobacco products. This transition is being driven by changing consumer behavior, increasing awareness of potentially reduced-risk products, and continued innovation in nicotine delivery technologies. As a result, tobacco companies must manage the decline of traditional cigarette volumes while simultaneously investing in new product categories that appeal to adult nicotine consumers.
The industry also operates in one of the world’s most heavily regulated environments. Manufacturers must comply with extensive federal, state, and local regulations governing product manufacturing, marketing, packaging, distribution, taxation, and sales. In the United States, new tobacco products generally require authorization from the U.S. Food and Drug Administration (FDA) before they can be commercially marketed. These regulatory requirements significantly increase the complexity, cost, and time required to introduce innovative products while creating uncertainty around future product approvals and commercialization.
In addition to regulatory challenges, the industry continues to face ongoing litigation and legal risks related to tobacco products. Companies regularly defend lawsuits involving smoking and health claims, e-vapor products, consumer protection statutes, and other legal matters. Tobacco manufacturers must also navigate increasing excise taxes, restrictions on product marketing, and evolving public health policies that influence consumer demand across product categories. These factors require companies to maintain strong legal, regulatory, scientific, and product development capabilities while preserving profitability in a mature market.
Altria believes addressing these challenges requires balancing the strength of its established tobacco brands with investment in next-generation smoke-free products. Its long-term strategy, “Moving Beyond Smoking,” focuses on responsibly transitioning adult smokers toward smoke-free alternatives, competing in emerging nicotine categories such as oral nicotine pouches, e-vapor, and heated tobacco products, and continuing to invest in research, product development, and regulatory science to support future innovation. By maintaining leadership in traditional tobacco products while expanding its smoke-free portfolio, Altria aims to adapt its business to changing consumer preferences and the evolving regulatory landscape.
Altria Group Business Model
Altria Group operates a brand-driven consumer products business model centered on developing, manufacturing, marketing, and distributing nicotine products for adult tobacco consumers in the United States. While combustible cigarettes remain its largest business, the company is transforming its portfolio through its “Moving Beyond Smoking” strategy, which focuses on expanding smoke-free alternatives such as oral nicotine pouches, e-vapor products, and heated tobacco products. By leveraging some of the strongest brands in the U.S. tobacco market, an extensive distribution network, and deep regulatory expertise, Altria seeks to maintain strong cash flows from its traditional businesses while investing in future growth categories.
The company’s business is organized into three reportable segments: Smokeable Products, Oral Tobacco Products, and E-Vapor Products. The Smokeable Products segment, led by the Marlboro brand, remains Altria’s primary source of revenue and profitability. Through Philip Morris USA, the company manufactures and markets premium cigarette brands, while John Middleton produces machine-made large cigars under the Black & Mild brand. These well-established brands benefit from strong consumer loyalty, premium pricing, and broad retail distribution across the United States.
To diversify beyond cigarettes, Altria has expanded into smoke-free nicotine categories. Its Oral Tobacco Products segment includes traditional moist smokeless tobacco brands such as Copenhagen, Skoal, and Red Seal, along with the rapidly growing on! nicotine pouch brand developed through Helix Innovations. In the E-Vapor Products segment, the company markets FDA-authorized vaping products through NJOY, while its 75% economic interest in Horizon Innovations, a joint venture with Japan Tobacco, positions it to commercialize heated tobacco products in the U.S. following regulatory authorization. These investments support Altria’s long-term objective of offering adult smokers a broader portfolio of smoke-free alternatives.
Another key element of Altria’s business model is its centralized support structure. Altria Group Distribution Company manages nationwide sales and distribution, ensuring broad retail availability of its products, while Altria Client Services provides research, regulatory affairs, legal, finance, technology, and consumer engagement services across the organization. This centralized approach allows individual operating companies to focus on brand development and product innovation while benefiting from shared corporate capabilities.
The company’s business model is built around generating strong cash flows from leading tobacco brands while allocating capital toward innovation, strategic investments, shareholder returns, and the expansion of smoke-free products. By combining premium brands, extensive distribution, regulatory expertise, and investments in emerging nicotine technologies, Altria aims to sustain its leadership in the U.S. nicotine market while adapting to evolving consumer preferences and industry dynamics.
How Altria Group Makes Money
Altria Group generates revenue by manufacturing, marketing, and selling nicotine products to adult tobacco consumers in the United States. Its revenue comes primarily from three product categories: Smokeable Products, Oral Tobacco Products, and E-Vapor Products. While cigarettes remain the company’s largest source of income, Altria is increasingly investing in smoke-free alternatives such as nicotine pouches, e-vapor devices, and heated tobacco products to support its long-term strategy of “Moving Beyond Smoking.” The company sells its products through wholesalers and distributors, which in turn supply retailers across the United States.
The Smokeable Products segment is Altria’s primary revenue generator. Through Philip Morris USA, the company sells premium cigarette brands led by Marlboro, which has been the best-selling cigarette brand in the United States for more than five decades. The segment also includes John Middleton’s Black & Mild cigars. In 2025, the Smokeable Products segment generated $22.1 billion in net revenues and $11.9 billion in adjusted operating companies income (OCI), making it the largest contributor to Altria’s earnings. Although cigarette shipment volumes continue to decline across the industry, Altria offsets much of this pressure through premium pricing, strong brand loyalty, and disciplined cost management.
The Oral Tobacco Products segment provides another important source of revenue through brands such as Copenhagen, Skoal, Red Seal, and the on! nicotine pouch brand. As consumer demand shifts toward smoke-free products, nicotine pouches have become one of the fastest-growing categories in the U.S. tobacco market. During 2025, the Oral Tobacco Products segment generated $3.1 billion in net revenues and $2.2 billion in adjusted OCI. Growth in the on! brand continues to support the company’s strategy of expanding beyond combustible cigarettes while leveraging its established distribution network.
Altria is also building its presence in the e-vapor market through NJOY, whose portfolio includes FDA-authorized vaping products. While the E-Vapor Products segment remains relatively small compared to cigarettes and oral tobacco, management views it as a strategic investment in the company’s smoke-free future. In addition, Altria owns a 75% economic interest in Horizon Innovations, a joint venture with Japan Tobacco that plans to commercialize heated tobacco products in the United States once FDA authorization is obtained, creating another potential future revenue stream.
Overall, Altria reported $24.0 billion in net revenues in 2025 and generated $8.5 billion in net earnings attributable to Altria. The company’s business model is highly cash generative, supported by premium tobacco brands, strong pricing power, efficient manufacturing, and an extensive retail distribution network. While traditional cigarette volumes are gradually declining, Altria aims to sustain long-term earnings by growing its smoke-free product portfolio, expanding into new nicotine categories, and leveraging its leading brands to maintain strong profitability and shareholder returns.
Future Outlook
Altria Group expects its long-term growth to be driven by the continued execution of its “Moving Beyond Smoking” strategy. The company is focused on responsibly transitioning adult smokers toward smoke-free alternatives while maintaining the strength of its leading combustible tobacco brands. Key priorities include expanding the on! oral nicotine pouch business, growing the NJOY e-vapor portfolio, and preparing to commercialize heated tobacco products in the United States through Horizon Innovations, its joint venture with Japan Tobacco, subject to FDA authorization. At the same time, Altria plans to continue investing in research and development, regulatory science, and product innovation to strengthen its smoke-free portfolio. Supported by its powerful brands, extensive distribution network, strong cash generation, and disciplined capital allocation, the company believes it is well positioned to adapt to changing consumer preferences while delivering long-term value to shareholders.
